NIH-funded research NIH-funded research

Inhaled Nitric Oxide for CDH: A pragmatic, multi-center trial to guide care for newborns with congenital diaphragmatic hernia

Official title: 1/2 Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia - The "NONO trial" - a pragmatic, multi-center, de-implementation, stepped-wedge, cluster-randomized trial

Funded at University of Texas Hlth Sci Ctr Houston · NIH-11261516 · Data updated 2026-11-12

This trial tests whether stopping routine inhaled nitric oxide use after birth helps seriously ill newborns with congenital diaphragmatic hernia.

More Congenital Diaphragmatic Hernia research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Sci Ctr Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startSeptember 17, 2024
Project endJune 30, 2032
Funding year2026
Award (this year)$697,451
NIH project number5U24HL166769-02
Project IDNIH-11261516 on NIH RePORTER

Who could benefit from this research

Could help

Infants diagnosed with congenital diaphragmatic hernia who require postnatal stabilization and are treated at participating centers.

Less likely to help

Babies not treated at participating sites or those outside the postnatal stabilization window may not benefit.

What this research studies

This project brings together several hospitals to study a common problem in babies born with diaphragmatic hernia. It uses a practical, real-world approach to change how care is delivered in the first days of life, aiming to reduce unnecessary treatments and costs. The study design is stepped-wedge and cluster-randomized to compare current practice with a streamlined care path across sites. Data from participating babies will be collected to understand outcomes and guide future clinical decisions. The goal is to improve stability and survival while avoiding ineffective or harmful interventions.

Why it matters

Potential benefit: If successful, this work could simplify early care for newborns with CDH and reduce exposure to ineffective treatments, potentially improving outcomes and lowering costs.

How similar studies have gone: Previous CDH trials faced enrollment and power challenges, but a collaborative, pragmatic design aims to produce clearer evidence for practice.

Where this research is happening

  • University of Texas Hlth Sci Ctr Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Harting, Matthew Tihen — University of Texas Hlth Sci Ctr Houston
  • Study coordinator: Harting, Matthew Tihen

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.